Abstract
Background Young children are frequently exposed to antibiotics for otitis media and respiratory infections, with the potential for collateral consequences on the gut microbiome. The impact of antibiotic exposures to off-target microbes (i.e., bacteria not targeted by antibiotic treatment) and antibiotic resistance genes (ARGs) is unknown.
Methods We used metagenomic sequencing data from paired stool samples collected prior to antibiotic exposure and at 1 year from over 200 infants and a difference-in-differences approach to assess the relationship between subsequent exposures and the abundance or compositional diversity of off-target microbes and ARGs while adjusting for covariates.
Results By 1 year, the relative abundance of multiple species and ARGs differed by antibiotic exposure. Compared to infants never exposed to antibiotics, Bacteroides vulgatus relative abundance increased by 1.72% (95%CI:0.19,3.24) while Bacteroides fragilis decreased by 1.56% (95%CI:-4.32,1.21). Bifidobacterium species also exhibited opposing trends suggesting differential antibiotic selection. Overall, antibiotic exposure was associated with a dose-dependent decrease in alpha diversity of off-target microbes. ARGs associated with antibiotic exposure included class A beta-lactamase gene CfxA6. Among infants attending day care, Escherichia coli and ARG abundance were both positively associated with antibiotic use.
Conclusion Further quantifying impacts to off-target microbes and ARGs has implications for antibiotic stewardship
Impact
Infants are frequently exposed to antibiotics for respiratory illnesses, but the extent of impact to off-target gut microbiota and antibiotic resistance genes is unknown.
We quantified these impacts in 2 cohort studies using a difference-in-differences approach. Novel to the microbiome space, this enabled us to use pre/post antibiotic data to emulate a randomized controlled trial.
Compared to infants unexposed to antibiotics between six weeks and 1 year, the relative abundance of multiple off-target species and antibiotic resistance genes was altered.
This research highlights the need to consider the microbiome in antibiotic stewardship and offers a new framework for quantifying change.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was funded in part by US National Institute Health under award numbers NIGMS P20GM104416, NIEHS P01ES022832 and P20ES018175, and NLM R01LM012723. Additional funds were provided by the US Environmental Protection Agency grants RD83459901 and RD83544201. RML funded under the Host-Microbe Interactions Training Grant at Dartmouth NIAID T32AI007519.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
For participants from the New Hampshire Birth Cohort Study, pregnant women and their children were recruited using the current Dartmouth Institutional Review Board approved procedures by the Center for the Protection of Human Subjects for the New Hampshire Birth Cohort Study. Data from participants in the DIABIMMUNE Study is publicly accessible.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Statement of financial support: This work was funded in part by US National Institute Health under award numbers NIGMS P20GM104416, NIEHS P01ES022832 and P20ES018175, and NLM R01LM012723. Additional funds were provided by the US Environmental Protection Agency grants RD83459901 and RD83544201. RML was funded under the Host-Microbe Interactions Training Grant at Dartmouth NIAID T32AI007519.
Disclosure statement: The authors declare no conflicts of interest.
Category of study: Population study
Consent statement: For participants from the New Hampshire Birth Cohort Study, pregnant women and their children were recruited using the New Hampshire Birth Cohort Study’s current Dartmouth Institutional Review Board approved procedures by the Center for the Protection of Human Subjects.
Data Availability
NHBCS whole metagenomic shotgun sequencing samples are available through the National Center for Biotechnology Information (NCBI) Sequence Read Archive: https://www.ncbi.nlm.nih.gov/sra (Accession number: PRJNA296814). Analytic R markdown scripts are available upon reasonable request.
